Ftse Mib
34.433,13
-0,49%
DAX
18.668,57
-0,31%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
69.939,41
-0,27%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX Helix BioPharma Corp (HBP) Helix BioPharma Corp (HBP) Notizie

HBP

Helix BioPharma (HBP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:HBP
DataOraFonteTitoloSimboloCompagnia
01/04/202415:13PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - HBPTSX:HBPHelix BioPharma Corp
01/04/202415:11PR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - HBPTSX:HBPHelix BioPharma Corp
28/03/202422:22PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - HBPTSX:HBPHelix BioPharma Corp
28/03/202422:14PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - HBPTSX:HBPHelix BioPharma Corp
26/05/201616:59PR Newswire (Canada)Helix BioPharma Corp. Opens the MarketTSX:HBPHelix BioPharma Corp
21/07/201415:15Marketwired CanadaHelix BioPharma Corp. Appoints New Independent Chair of the BoardTSX:HBPHelix BioPharma Corp
12/06/201415:00MarketwiredHelix BioPharma Corp. Announces Fiscal Q3 2014 ResultsTSX:HBPHelix BioPharma Corp
14/05/201414:00MarketwiredHelix Biopharma Corp. Submits L-DOS47 Clinical Trial Application With Health CanadaTSX:HBPHelix BioPharma Corp
22/04/201414:30MarketwiredHelix BioPharma Corp. Receives U.S. Food & Drug Administration Approval to Initiate a Clinical Trial of L-DOS47 in Combinatio...TSX:HBPHelix BioPharma Corp
07/04/201422:30MarketwiredHelix BioPharma Corp. Initiates Enrollment for Eighth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Cand...TSX:HBPHelix BioPharma Corp
03/04/201423:14MarketwiredHelix BioPharma Corp. Submits L-DOS47 Investigational New Drug Application With U.S. Food and Drug AdministrationTSX:HBPHelix BioPharma Corp
14/03/201422:00MarketwiredHelix BioPharma Corp. Announces Fiscal Q2 2014 ResultsTSX:HBPHelix BioPharma Corp
11/03/201422:00MarketwiredHelix BioPharma Corp. Announces Appointment of New Director and Observer to the Board of DirectorsTSX:HBPHelix BioPharma Corp
18/02/201423:40MarketwiredHelix BioPharma Corp. Initiates Enrollment for Seventh Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Can...TSX:HBPHelix BioPharma Corp
22/01/201423:13MarketwiredHelix BioPharma Corp. Initiates Enrollment for Sixth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candi...TSX:HBPHelix BioPharma Corp
10/01/201416:36MarketwiredDirector of Helix BioPharma Corp. Acquires a Further 1,000,000 Common SharesTSX:HBPHelix BioPharma Corp
19/12/201305:07MarketwiredHelix Announces the Results of Its Annual General and Special MeetingTSX:HBPHelix BioPharma Corp
17/12/201314:59MarketwiredHelix BioPharma Announces Director ResignationTSX:HBPHelix BioPharma Corp
14/12/201300:29MarketwiredHelix BioPharma Corp. Announces Fiscal Q1 2014 ResultsTSX:HBPHelix BioPharma Corp
06/12/201323:00MarketwiredHelix BioPharma Corp. Announces Changes in Senior ManagementTSX:HBPHelix BioPharma Corp
05/11/201322:15Marketwired CanadaClear Mountain Enters Into Binding Letter of Intent to Acquire US$108 Million Oil and Gas AssetTSX:HBPHelix BioPharma Corp
30/09/201313:30MarketwiredHelix BioPharma Corp. Initiates Enrollment for Fifth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candi...TSX:HBPHelix BioPharma Corp
09/09/201313:16MarketwiredHelix BioPharma Corp. to Conduct Interim Review of Its LDOS002 Phase I/II Clinical StudyTSX:HBPHelix BioPharma Corp
05/09/201322:30MarketwiredHelix BioPharma Corp. to Present at Rodman & Renshaw Annual Global Investment ConferenceTSX:HBPHelix BioPharma Corp
28/08/201316:15MarketwiredHelix BioPharma Corp. Establishes Polish SubsidiaryTSX:HBPHelix BioPharma Corp
23/08/201314:30MarketwiredHelix BioPharma Corp. Announces Extension of 2009 Warrant Expiry DateTSX:HBPHelix BioPharma Corp
19/07/201323:05MarketwiredHelix BioPharma Corp. Announces Extension of 2010 Warrant Expiry DateTSX:HBPHelix BioPharma Corp
12/07/201313:53MarketwiredHelix BioPharma Announces Change of AuditorTSX:HBPHelix BioPharma Corp
18/06/201314:26MarketwiredHelix BioPharma Corp. Announces Q3 Fiscal 2013 ResultsTSX:HBPHelix BioPharma Corp
13/06/201323:05MarketwiredHelix BioPharma Announces Appointment of DirectorTSX:HBPHelix BioPharma Corp
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:HBP

La tua Cronologia

CSE
ALQ
ALQ Gold Corp.
BIT
P1PM09
BNP Paribas Issuance
GATE
SDAOBTC
Singularity Dao
ASX
ADDDA
BIT
I06551
Banca Imi
LSE
MIXT
Matrix Income & Growth Vct 3
BIT
P14GK0
BNP Paribas Issuance
GATE
SPIETH
Shopping.io
USOTC
LUCRF
Lurcara Diamond (PK)
COIN
NCTTUST
NameChangeToken
EU
S547S
S547S
USOTC
LGHHF
LG Household and Healthc... (PK)
EU
RABK
Regie Autonome des Trans...
LSE
STGR
NYSE
JPM-D
JP Morgan Chase
LQID
BCHUSD
Bitcoin Cash
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network